INVO logo

INVO Bioscience (INVO) Cash From Investing

Annual CFI

-$2.49 M
-$2.41 M-2972.54%

December 31, 2023

Summary

Performance

1-Year Change

-2972.54%

3-Year Change

-1232.03%

5-Year Change

-12760.31%

15-Year Change

-100%

INVO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$0.00
INVO annual cash flow from investing activities is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$2.49 M
INVO annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
INVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
INVO next annual earnings announcement has not yet been scheduled

OtherINVOcash flowmetrics:

Annual CFF

$7.39 M
INVO annual cash flow from financing activities is $7.39 million

Annual CFO

-$4.76 M
INVO annual cash flow from operations is -$4.76 million

Annual FCF

-$5.20 M
INVO annual free cash flow is -$5.20 million

Annual CAPEX

$444.70 K
INVO annual capital expenditures is $444.70 thousand

Quarterly CFI

$0.00
+$5100.00+100.00%

September 30, 2024

Summary

Performance

3-Month Change

+100%

1-Year Change

+100%

3-Year Change

+100%

5-Year Change

+100%

INVO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$33.30 K
INVO quarterly cash flow from investing activities is currently -100.00% below its historical high of $33.30 thousand

3-Year Low

-$2.26 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
INVO next earnings announcement has not yet been scheduled

OtherINVOcash flowmetrics:

Quarterly CFF

$169.46 K
INVO quarterly cash flow from financing activities is $169.46 thousand

Quarterly CFO

-$640.81 K
INVO quarterly cash flow from operations is -$640.81 thousand

Quarterly FCF

-$640.81 K
INVO quarterly free cash flow is -$640.81 thousand

Quarterly CAPEX

-
INVO quarterly capital expenditures value is unknown

TTM CFI

$4100.00
+$2.26 M+100.18%

September 30, 2024

Summary

Performance

3-Month Change

+100.18%

1-Year Change

+100.16%

3-Year Change

+100.21%

5-Year Change

+100.21%

INVO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4100.00
INVO TTM cash flow from investing activities is currently at an all-time high

3-Year Low

-$2.52 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
INVO next earnings announcement has not yet been scheduled

OtherINVOcash flowmetrics:

TTM CFF

$2.48 M
INVO TTM cash flow from financing activities is $2.48 million

TTM CFO

-$3.07 M
INVO TTM cash flow from operations is -$3.07 million

TTM FCF

-$3.25 M
INVO TTM free cash flow is -$3.25 million

TTM CAPEX

-
INVO TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

INVO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2972.5%+100.0%+100.2%
3 y3 years-1232.0%+100.0%+100.2%
5 y5 years-10000.0%+100.0%+100.2%

INVO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+2972.5%at low-100.0%<-9999.0%at high<-9999.0%
5 y5-year+2972.5%at low-100.0%<-9999.0%at high<-9999.0%
alltimeall time<-9999.0%at low-100.0%<-9999.0%at high<-9999.0%

INVO Bioscience Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(-100.0%)
$4100.00(-100.2%)
Jun 2024
-
-$5100.00(-78.8%)
-$2.25 M(-10.2%)
Mar 2024
-
-$24.10 K(-172.4%)
-$2.51 M(+0.6%)
Dec 2023
-$2.49 M(+2972.5%)
$33.30 K(-101.5%)
-$2.49 M(-1.0%)
Sep 2023
-
-$2.26 M(+763.6%)
-$2.52 M(+853.3%)
Jun 2023
-
-$261.50 K(+3013.1%)
-$264.30 K(+3332.5%)
Mar 2023
-
-$8400.00(-197.7%)
-$7700.00(-90.5%)
Dec 2022
-$81.20 K(-96.2%)
$8600.00(-386.7%)
-$81.20 K(-91.9%)
Sep 2022
-
-$3000.00(-38.8%)
-$1.01 M(-23.9%)
Jun 2022
-
-$4900.00(-94.0%)
-$1.32 M(-31.2%)
Mar 2022
-
-$81.90 K(-91.1%)
-$1.93 M(-10.5%)
Dec 2021
-$2.15 M(+1049.8%)
-$917.80 K(+186.5%)
-$2.15 M(+61.6%)
Sep 2021
-
-$320.30 K(-47.2%)
-$1.33 M(+24.2%)
Jun 2021
-
-$606.40 K(+96.2%)
-$1.07 M(+127.7%)
Mar 2021
-
-$309.00 K(+219.9%)
-$471.20 K(+151.6%)
Dec 2020
-$187.30 K(+63.3%)
-$96.60 K(+58.4%)
-$187.30 K(+106.5%)
Sep 2020
-
-$61.00 K(+1226.1%)
-$90.70 K(+13.9%)
Jun 2020
-
-$4600.00(-81.7%)
-$79.60 K(-12.9%)
Mar 2020
-
-$25.10 K(<-9900.0%)
-$91.40 K(-20.3%)
Dec 2019
-$114.70 K
$0.00(-100.0%)
-$114.70 K(-14.5%)
Sep 2019
-
-$49.90 K(+204.3%)
-$134.10 K(+59.3%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$16.40 K(-66.1%)
-$84.20 K(+24.2%)
Mar 2019
-
-$48.40 K(+149.5%)
-$67.80 K(+249.5%)
Dec 2018
-$19.40 K(<-9900.0%)
-$19.40 K(<-9900.0%)
-$19.40 K(<-9900.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2017
$0.00(-100.0%)
-
-
Dec 2016
-$15.70 K(<-9900.0%)
-$7700.00(-3.8%)
-$15.70 K(+96.3%)
Sep 2016
-
-$8000.00(<-9900.0%)
-$8000.00(<-9900.0%)
Dec 2015
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2015
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2011
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2010
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2010
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2009
-
$0.00(-100.0%)
-$66.60 K(-9.9%)
Dec 2008
-$73.90 K(<-9900.0%)
-$73.90 K(-1112.3%)
-$73.90 K(<-9900.0%)
Sep 2008
-
$7300.00(-200.0%)
$0.00(-100.0%)
Jun 2008
-
-$7300.00(<-9900.0%)
-$7300.00(<-9900.0%)
Mar 2008
-
$0.00
$0.00
Dec 2007
$0.00
-
-

FAQ

  • What is INVO Bioscience annual cash flow from investing activities?
  • What is the all time high annual CFI for INVO Bioscience?
  • What is INVO Bioscience annual CFI year-on-year change?
  • What is INVO Bioscience quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for INVO Bioscience?
  • What is INVO Bioscience quarterly CFI year-on-year change?
  • What is INVO Bioscience TTM cash flow from investing activities?
  • What is the all time high TTM CFI for INVO Bioscience?
  • What is INVO Bioscience TTM CFI year-on-year change?

What is INVO Bioscience annual cash flow from investing activities?

The current annual CFI of INVO is -$2.49 M

What is the all time high annual CFI for INVO Bioscience?

INVO Bioscience all-time high annual cash flow from investing activities is $0.00

What is INVO Bioscience annual CFI year-on-year change?

Over the past year, INVO annual cash flow from investing activities has changed by -$2.41 M (-2972.54%)

What is INVO Bioscience quarterly cash flow from investing activities?

The current quarterly CFI of INVO is $0.00

What is the all time high quarterly CFI for INVO Bioscience?

INVO Bioscience all-time high quarterly cash flow from investing activities is $33.30 K

What is INVO Bioscience quarterly CFI year-on-year change?

Over the past year, INVO quarterly cash flow from investing activities has changed by +$24.10 K (+100.00%)

What is INVO Bioscience TTM cash flow from investing activities?

The current TTM CFI of INVO is $4100.00

What is the all time high TTM CFI for INVO Bioscience?

INVO Bioscience all-time high TTM cash flow from investing activities is $4100.00

What is INVO Bioscience TTM CFI year-on-year change?

Over the past year, INVO TTM cash flow from investing activities has changed by +$2.51 M (+100.16%)